These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2666085)

  • 1. Use of pharmacokinetics when dealing with the drug residue problem in food-producing animals.
    Ludwig B
    Dtsch Tierarztl Wochenschr; 1989 May; 96(5):243-8. PubMed ID: 2666085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Scientific basis in the setting of residue limits for veterinary drugs in food of animal origin taking into account the presence of their metabolites].
    Mitsumori K
    Eisei Shikenjo Hokoku; 1993; (111):148-9. PubMed ID: 7920562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food Safety and Inspection Service initiatives for tissue residue reduction in meat and poultry.
    Norcross MA; Brown JL
    J Am Vet Med Assoc; 1991 Mar; 198(5):819-24. PubMed ID: 2026528
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic principles of residue avoidance for veterinary practitioners.
    Riviere JE
    J Am Vet Med Assoc; 1991 Mar; 198(5):809-16. PubMed ID: 2026526
    [No Abstract]   [Full Text] [Related]  

  • 5. [General and special problems concerning the approval and re-evaluation of antimicrobial agents for use in agriculturally useful animals].
    Hoffmann B
    Tierarztl Prax; 1988; 16(2):103-7. PubMed ID: 3047907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Maximum residue levels (MRL's) of veterinary medicines in relation to food safety. MRL's really do matter--the Benzaprocpen case].
    Vaarkamp H
    Tijdschr Diergeneeskd; 2002 Jan; 127(1):2-6. PubMed ID: 11795030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug residues in animal tissues and their regulatory significance--the Canadian point of view.
    Campbell DJ
    J Assoc Off Anal Chem; 1978 Sep; 61(5):1194-7. PubMed ID: 721731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the food animal residue avoidance databank.
    Sundlof SF; Craigmill AL; Riviere JE
    J Am Vet Med Assoc; 1991 Mar; 198(5):816-9. PubMed ID: 2026527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consideration of sheep as a minor species: comparison of drug metabolism and disposition with other domestic ruminants.
    Short CR
    Vet Hum Toxicol; 1993; 35 Suppl 2():40-56. PubMed ID: 8236767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simulation model for the prediction of tissue:plasma partition coefficients for drug residues in natural casings.
    Haritova AM; Fink-Gremmels J
    Vet J; 2010 Sep; 185(3):278-84. PubMed ID: 19709908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The occurrence and metabolism of physiologically normal-appearing hydrocarbons in agricultural animals].
    Lusky K; Stoyke M
    Dtsch Tierarztl Wochenschr; 1991 Oct; 98(10):381-3. PubMed ID: 1752208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools to evaluate pharmacokinetics data for establishing maximum residue limits for approved veterinary drugs: examples from JECFA's work.
    Sanders P; Henri J; Laurentie M
    Drug Test Anal; 2016 May; 8(5-6):565-71. PubMed ID: 27443212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residue analysis: Future trends from a historical perspective.
    De Brabander HF; Noppe H; Verheyden K; Vanden Bussche J; Wille K; Okerman L; Vanhaecke L; Reybroeck W; Ooghe S; Croubels S
    J Chromatogr A; 2009 Nov; 1216(46):7964-76. PubMed ID: 19272610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past, present and future of mass spectrometry in the analysis of residues of banned substances in meat-producing animals.
    De Brabander HF; Le Bizec B; Pinel G; Antignac JP; Verheyden K; Mortier V; Courtheyn D; Noppe H
    J Mass Spectrom; 2007 Aug; 42(8):983-98. PubMed ID: 17657726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residues from veterinary medicinal products, growth promoters and performance enhancers in food-producing animals: a European Union perspective.
    Serratosa J; Blass A; Rigau B; Mongrell B; Rigau T; Tortadès M; Tolosa E; Aguilar C; Ribó O; Balagué J
    Rev Sci Tech; 2006 Aug; 25(2):637-53. PubMed ID: 17094703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model.
    Abd El-Aty AM; Goudah A; Abo El Sooud K
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):168-71. PubMed ID: 11370478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the toxicity of drug residues in food: the case for 'relay' toxicity studies.
    Galer DM; Monro AM
    Food Addit Contam; 1998; 15(4):494-500. PubMed ID: 9764221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of pharmacokinetic parameters for effective drug therapy in house and domestic animals].
    Kietzmann M; Löscher W
    Berl Munch Tierarztl Wochenschr; 1991 Nov; 104(11):365-9. PubMed ID: 1772390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacokinetics of common chemotherapeutic drugs used in veterinary medicine].
    Lutz F
    Tierarztl Prax; 1988; 16(2):113-8. PubMed ID: 3047909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyano metabolite as a biomarker of nitrofurazone in channel catfish.
    Wang Y; Jester EL; El Said KR; Abraham A; Hooe-Rollman J; Plakas SM
    J Agric Food Chem; 2010 Jan; 58(1):313-6. PubMed ID: 19950980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.